Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: Endoscopic papillectomy (EP) is the gold standard treatment for ampullary adenomas. However, EP is still burdened by a nonnegligible rate of incomplete resections (IR). Different predictors have been linked to higher rates of IR, but the interaction between these factors is still unclear. The aim of the study was to develop a scoring system (hereby called PANETH score) able to quantify the risk of IR after EP.

Methods: Patients who underwent EP in 19 Italian centers in 2016-2021 were included. IR was defined as the presence of residual tumor in lateral or endoampullary margins after EP. Predictors for IR were analyzed by logistic regression and were used to obtain an easy-to-use numeric score. The performance of the model was evaluated with a receiver operating characteristic curve analysis and tested by means of 10-fold cross-validation.

Results: A total of 430 patients were included. On multivariate analysis, laterally spreading tumor (odds ratio [OR] 5.81, 3.21-7.65; P = 0.02), intraductal extension (OR 6.92, 3.33-9.87; P < 0.0001), and bile duct dilation (OR 2.61, 1.22-4.32; P = 0.004) were significant predictors of IR. The score was calculated by the sum of regression coefficients of each predictor. A ≥3 score indicated a 4-fold risk of IR (P < 0.0001). The internal validation resulted in an area under the curve of 0.83 and an overall error rate of 0.11.

Conclusions: The proposed PANETH score may represent a reliable and easily applicable tool to predict the risk of IR after EP to optimize patient selection and risk stratification.

Download full-text PDF

Source
http://dx.doi.org/10.1111/den.15005DOI Listing

Publication Analysis

Top Keywords

endoscopic papillectomy
8
paneth score
8
development validation
4
validation risk
4
score
4
risk score
4
score incomplete
4
incomplete resection
4
resection endoscopic
4
papillectomy paneth
4

Similar Publications

Background/aims: Ampullary adenomas are precancerous lesions requiring accurate diagnosis and timely intervention to prevent malignant transformation. Endoscopic papillectomy (EP) has emerged as a less invasive alternative to surgery; however, technical variations in practice remain. This study evaluated contemporary real-world approaches to the diagnosis, treatment, and surveillance of ampullary adenomas among pancreatobiliary endoscopists.

View Article and Find Full Text PDF

Background/aim: Endoscopic submucosal dissection (ESD) can be performed to treat laterally spreading duodenal papillary tumors (LSPTs). However, no studies have been conducted on the outcomes of ESDs for LSPTs.

Methods: We retrospectively compared 47 patients who underwent endoscopic papillectomies (EPs) for papillary tumors (PTs) between June 2007 and July 2023 (EP group) and eight patients who underwent ESDs for LSPTs between February 2022 and July 2023 (ESD group).

View Article and Find Full Text PDF

Background: Endoscopic papillectomy (EP) has been used for the treatment of duodenal papillectomy, and the results of preoperative endoscopic biopsy are important for the selection of treatment plans for the patients. However, some lesions cannot be precisely diagnosed based solely on biopsy results. In the study, we attempted to assess the accuracy of histopathological diagnosis of endoscopic forceps biopsy and to avoid over - or under-treatment.

View Article and Find Full Text PDF

Background And Study Aims: Endoscopic papillectomy (EP) is an effective endoscopic modality for managing ampullary lesions. This study aimed to evaluate predictors for recurrence and adverse events (AEs) in patients who underwent EP for major papilla lesions.

Patients And Methods: This was a retrospective analysis of all patients who underwent endoscopic snare papillectomy for a major papilla lesion between January 2006 and December 2021.

View Article and Find Full Text PDF